• Clinical Trial Trends: 18 Months of Faster Tech Adoption, Real World Data, Increased Collaboration

    Sep 22 | Clinical Research News | Namita Limaye, Research VP at IDC, gave a broad overview of IDC’s survey findings over the past 18 months at this week’s Bio-IT World Conference and Expo held in Boston and online. She highlighted trends in the life sciences and clinical trials industries that included increased collaboration, speedier adoption of technologies, reliance on real world data, and more. More
  • Machine Learning Adds Speed To Electronic Health Records-Based Phenotyping

    Sep 21 | Clinical Research News | In clinical informatics research, creation of rule-based algorithms is a robust method for mining electronic health records (EHRs) to classify diagnoses. But the process requires considerable time and expertise to build, refine, and deploy, which explains why to date only 81 phenotypes have a publicly available algorithm. More
  • Real-World Data Suggests Statins Would Effectively Treat Ulcerative Colitis

    Sep 16 | Clinical Research News | Researchers at Stanford have published close to 100 papers demonstrating that publicly-available data can be tapped to accelerate clinical translation. They have now integrated real-world molecular and clinical data to show, with astonishing clarity, that statins—the commonly prescribed cholesterol-lowering drug—would be an effective, if unexpected, treatment for ulcerative colitis (UC). More
  • Foundation Medicine, Science 37 Decentralize Trial For Rare Cancer

    Sep 15 | Clinical Research News | Cancer-gene profiling company Foundation Medicine has teamed up with decentralized clinical trial specialist Science 37 to enable home-based clinical trials in oncology. The pilot project with Roche employing this model was launched last December. More
  • ClinOne Launches Oncology Tool Platform

    Sep 14 | Clinical Research News | Later this month, ClinOne will announce a new technology platform specifically for oncology clinical trials, bringing together its solutions for peer referrals, eConsent, video visits, Uber Health, and patient empowerment into a single platform More
  • How To Diversify Trials: Recruitment Protocols, Other Approaches

    Sep 09 | Clinical Research News | Researchers from Beth Israel Deaconess Medical Center (BIDMC) recently reviewed investigators’ planning documents in federally-funded cardiovascular disease trials to determine whether various recruitment strategies impacted the number of Black participants enrolled. They were disappointed by what they found, but others say real-world evidence—not just better recruitment—will most move the needle. More
  • New Drug Repurposing Approach Could Speed COVID Therapies To The Clinic

    Sep 07 | Clinical Research News | In under a year, researchers at the University of Michigan (U-M) have moved from discovery to phase 2 clinical studies for a pair of drug contenders in the fight against COVID-19. The credit goes to a program, newly launched when the pandemic struck, which “systemizes” drug repurposing by helping academic investigators look for existing drugs before trying to create new ones More
  • Follow the Money: Patient Recruitment, Decentralized Trials, AI in Research

    Sep 03 | Clinical Research News | HealthTech SPAC funding, platforms for patient recruitment and decentralized trials, multiple academic grants for dementia research, using AI to watch cells over time, and more. More
  • Foundation Medicine Integrates with Epic, Launch of Sickle Cell Disease Clin Trials Network, New Products

    Sep 01 | Clinical Research News | New video eConsent capabilities from Medidata, Kaia Health revamps C-Suite to expand clinical capabilities, clinical trial partnerships for Curebase, Adagene, and Telix Pharmaceuticals, and Clinerion expands global hospital network. Plus new products from Smart Meter, Digital Science, and Elsevier. More
  • Biosafety Oversight: A Critical Component of Clinical Gene Transfer Research

    Aug 31 | Clinical Research News | The goal of biosafety in research is the management of risk to people and the environment associated with exposure to biological agents and toxins and to genetically modified vectors, DNA or RNA. There are two ways that biosafety oversight of clinical trials could be improved to become more consistent and transparent. First, federal rules governing which clinical trials require biosafety approval should be broadened and clarified. Second, the National Institutes of Health (NIH) could restore certain aspects of central risk assessment and guidance that were eliminated recently. More
View more articles

DIA NOW is the source for life science knowledge. Comprehensive and customizable, and backed by DIA's extensive history, global reach, and experience, you'll stay on top of trends and receive up-to-the-minute updates on a wide variety of critical issues in the life sciences arena. Get your one-month free trial today!